Stay current with insights from our analysts and industry updates. We also offer customised newsletters to keep your management, sales and marketing teams fully informed - contact us to find out more.
01-Feb-15 Over ten years the Global Fund initiative in China has successfully addressed several major public health problems. Access to diagnosis and treatment of tuberculosis expanded from two pilot projects in 2006 to 92 sites in 30 provinces by 2013. Between 2002 and 2012 the number of malaria cases fell from over 100,000 to less than 5,000. Finally, China's rate of HIV infection was stabilised at 0.06%. [image: Snipview]Read More
31-Jan-15 Japan's Chugai Pharmaceutical will invest $476 million over the next seven years to expand its research institute in Singapore. The investment will make its centre at Biopolis one of the biggest pharmaceutical research and development operations in Singapore. It will also boost its "local employee base and antibody research and development pipeline", the company said. [image: Reuters]Read More
31-Jan-15 India has a huge demand for healthcare and consequently for medical devices and equipment. However, setting up a distribution network for selling equipment in India is no mean task. There are very few distributors with full nationwide coverage. Manufacturers need to forge multiple relationships to establish a pan-India network, and must also be aware of pitfalls such as non-performing exclusive partners, unethical practices and the difficulties of providing after-sales service. [image: Euro Kerala Tour]Read More
30-Jan-15 China's mobile healthcare market is expected to see fast growth and hit 12.5 billion yuan (USD2 billion) by 2017, according to the China Medical Pharmaceutical Material Association. There are already more than 2,000 mobile healthcare applications in China and 527 million mobile Internet users. [image: mHealthWatch]Read More
28-Jan-15 In the Middle East & Africa non-communicable diseases (NCDs) are predicted to cost over USD68 billion by 2022, and by 2030 almost 80% of deaths will result from NCDs. The region is lagging behind on gathering and sharing clinical data. However, linking patients, doctors and hospital equipment using Big Data could bring quality healthcare much closer to home for all in the Middle East. [image: The Pulse / GE Healthcare]Read More
GGM is a research and advisory firm helping clients grow profitably in international markets.
We believe the only way to understand a market properly is on the ground. Intelligence from our in-country consultants gives you a competitive advantage in China, Asia, Latin America, the Middle East, Africa and other opportunity areas.
Our clients benefit from accurate data, reliable insights and strategic advice, giving them the confidence to make better business decisions and succeed in their global growth markets.
Enter your work email to receive our free GROW newsletter on international market intelligence and strategy.
Successful track record in your sector since 1992
In-country research consultants in over 40 markets
Value for money - quality results at affordable rates
Work led by senior directors with >20 years experience
Proven frameworks for data analysis and strategy
Pragmatic advice based on accurate data and reliable insights
Get in touch to discuss your growth markets research and advisory needs: